US Patent RE49238 Alleviating oxidative stress disorders with PUFA derivatives
Patent RE49238 was granted and assigned to Retrotope Inc. on October, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 19, 2020
Date of Patent
October 11, 2022
Patent Applicant
Patent Application Number
16997692
Patent Citations
Patent Inventor Names
Mikhail S. Shchepinov
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent RE49238 Alleviating oxidative stress disorders with PUFA derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.